Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Masamoto Murakami

Showing results (11-20 of 71) with videos related to

Pageof 8
Sort By:
Cureus|July 4, 2024
A Successful Switch From Ustekinumab to an Extended Dosing Interval of Guselkumab Without Induction in a Patient With Psoriasis VulgarisKazuki Yatsuzuka, Jun Muto, Ken Shiraishi, et al.
The Journal of Dermatology|December 15, 2007
Nodular malignant melanoma with Spitz nevus-like pathological features finally confirmed by the pathological feature of the sentinel lymph nodeMasamoto Murakami, Takashi Wada, Takayuki Kashiwagi, et al.
Pediatric Research|March 4, 2003
Neonatal skin in mice and humans expresses increased levels of antimicrobial peptides: innate immunity during development of the adaptive responseRobert A Dorschner, Kenneth H Lin, Masamoto Murakami, et al.
Experimental Dermatology|July 8, 2011
Patients with palmoplantar pustulosis have increased IL-17 and IL-22 levels both in the lesion and serumMasamoto Murakami, Eva Hagforsen, Vera Morhenn, et al.
JID Innovations : Skin Science From Molecules to Population Health|July 13, 2023
Nuclear IL-33 Plays an Important Role in EGFR-Mediated Keratinocyte Migration by Regulating the Activation of Signal Transducer and Activator of Transcription 3 and NF-κBXiuju Dai, Ken Shiraishi, Jun Muto, et al.
JAMA Dermatology|February 9, 2018
Efficacy and Safety of Guselkumab, an Anti-interleukin 23 Monoclonal Antibody, for Palmoplantar Pustulosis: A Randomized Clinical TrialTadashi Terui, Satomi Kobayashi, Yukari Okubo, et al.
Dermatology (Basel, Switzerland)|October 7, 2015
Cefcapene Pivoxil Hydrochloride Is a Potentially New Treatment for Palmoplantar Pustulosis with Pustulotic Arthro-OsteitisMasamoto Murakami, Kana Masuda, Ryo Utsunomiya, et al.
Journal of Immunology (Baltimore, Md. : 1950)|February 24, 2004
Postsecretory processing generates multiple cathelicidins for enhanced topical antimicrobial defenseMasamoto Murakami, Belen Lopez-Garcia, Marissa Braff, et al.
Plos One|February 14, 2012
Lamellar granule secretion starts before the establishment of tight junction barrier for paracellular tracers in mammalian epidermisAkemi Ishida-Yamamoto, Mari Kishibe, Masamoto Murakami, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|November 15, 2025
Efficacy and safety of brodalumab in palmoplantar pustulosis: A 68-week randomized Phase 3 trialMasamoto Murakami, Yukari Okubo, Satomi Kobayashi, et al.
Pageof 8

Showing results (11-20 of 71) with videos related to

Sort By:
Pageof 8
Cureus|July 4, 2024
A Successful Switch From Ustekinumab to an Extended Dosing Interval of Guselkumab Without Induction in a Patient With Psoriasis VulgarisKazuki Yatsuzuka, Jun Muto, Ken Shiraishi, et al.
The Journal of Dermatology|December 15, 2007
Nodular malignant melanoma with Spitz nevus-like pathological features finally confirmed by the pathological feature of the sentinel lymph nodeMasamoto Murakami, Takashi Wada, Takayuki Kashiwagi, et al.
Pediatric Research|March 4, 2003
Neonatal skin in mice and humans expresses increased levels of antimicrobial peptides: innate immunity during development of the adaptive responseRobert A Dorschner, Kenneth H Lin, Masamoto Murakami, et al.
Experimental Dermatology|July 8, 2011
Patients with palmoplantar pustulosis have increased IL-17 and IL-22 levels both in the lesion and serumMasamoto Murakami, Eva Hagforsen, Vera Morhenn, et al.
JID Innovations : Skin Science From Molecules to Population Health|July 13, 2023
Nuclear IL-33 Plays an Important Role in EGFR-Mediated Keratinocyte Migration by Regulating the Activation of Signal Transducer and Activator of Transcription 3 and NF-κBXiuju Dai, Ken Shiraishi, Jun Muto, et al.
JAMA Dermatology|February 9, 2018
Efficacy and Safety of Guselkumab, an Anti-interleukin 23 Monoclonal Antibody, for Palmoplantar Pustulosis: A Randomized Clinical TrialTadashi Terui, Satomi Kobayashi, Yukari Okubo, et al.
Dermatology (Basel, Switzerland)|October 7, 2015
Cefcapene Pivoxil Hydrochloride Is a Potentially New Treatment for Palmoplantar Pustulosis with Pustulotic Arthro-OsteitisMasamoto Murakami, Kana Masuda, Ryo Utsunomiya, et al.
Journal of Immunology (Baltimore, Md. : 1950)|February 24, 2004
Postsecretory processing generates multiple cathelicidins for enhanced topical antimicrobial defenseMasamoto Murakami, Belen Lopez-Garcia, Marissa Braff, et al.
Plos One|February 14, 2012
Lamellar granule secretion starts before the establishment of tight junction barrier for paracellular tracers in mammalian epidermisAkemi Ishida-Yamamoto, Mari Kishibe, Masamoto Murakami, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|November 15, 2025
Efficacy and safety of brodalumab in palmoplantar pustulosis: A 68-week randomized Phase 3 trialMasamoto Murakami, Yukari Okubo, Satomi Kobayashi, et al.
Pageof 8